Cargando…

High Acetate Concentration Protects Intestinal Barrier and Exerts Anti-Inflammatory Effects in Organoid-Derived Epithelial Monolayer Cultures from Patients with Ulcerative Colitis

Short-chain fatty acids as well as their bacterial producers are of increasing interest in inflammatory bowel diseases. Although less studied compared to butyrate, acetate might also be of interest as it may be less toxic to epithelial cells, stimulate butyrate-producing bacteria by cross-feeding, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deleu, Sara, Arnauts, Kaline, Deprez, Lowie, Machiels, Kathleen, Ferrante, Marc, Huys, Geert R. B., Thevelein, Johan M., Raes, Jeroen, Vermeire, Séverine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821118/ https://www.ncbi.nlm.nih.gov/pubmed/36614212 http://dx.doi.org/10.3390/ijms24010768

Ejemplares similares

Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis
por: Vancamelbeke, Maaike, et al.
Publicado: (2019)

Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
por: Deleu, Sara, et al.
Publicado: (2021)

Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD
por: Poletti, Martina, et al.
Publicado: (2020)

Microbiota, not host origin drives ex vivo intestinal epithelial responses
por: Arnauts, Kaline, et al.
Publicado: (2022)

Community Types of the Human Gut Virome are Associated with Endoscopic Outcome in Ulcerative Colitis
por: Jansen, Daan, et al.
Publicado: (2023)

Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All
por: Sudhakar, Padhmanand, et al.
Publicado: (2022)

Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon
por: Verstockt, Bram, et al.
Publicado: (2020)

Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases
por: Verstockt, Bram, et al.
Publicado: (2020)

Comparisons of gut microbiota profiles in wild-type and gelatinase B/matrix metalloproteinase-9-deficient mice in acute DSS-induced colitis
por: de Bruyn, Magali, et al.
Publicado: (2018)

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
por: Sabino, João, et al.
Publicado: (2016)

Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007)

Integrated miRNA and mRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis
por: Van der Goten, Jan, et al.
Publicado: (2014)

Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis
por: Lee, Ho-Su, et al.
Publicado: (2020)

Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis
por: Faelens, Ruben, et al.
Publicado: (2021)

Culture and differentiation of rabbit intestinal organoids and organoid-derived cell monolayers
por: Kardia, Egi, et al.
Publicado: (2021)

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
por: Verstockt, Sare, et al.
Publicado: (2021)

Increased Proportion of Colorectal Cancer in Patients With Ulcerative Colitis Undergoing Surgery in the Netherlands
por: Heuthorst, Lianne, et al.
Publicado: (2023)

Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC
por: Conceição-Neto, Nádia, et al.
Publicado: (2018)

Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host Interactions
por: Sudhakar, Padhmanand, et al.
Publicado: (2021)

Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells
por: Creyns, Brecht, et al.
Publicado: (2020)

Anion Transport Across Human Gallbladder Organoids and Monolayers
por: Zarei, Keyan, et al.
Publicado: (2022)

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Etrolizumab for the Treatment of Ulcerative Colitis and Crohn’s Disease: An Overview of the Phase 3 Clinical Program
por: Sandborn, William J., et al.
Publicado: (2020)

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
por: Winthrop, Kevin L, et al.
Publicado: (2018)

Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13
por: Creyns, Brecht, et al.
Publicado: (2019)

New biologics and small molecules in inflammatory bowel disease: an update
por: Sabino, João, et al.
Publicado: (2019)

Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity
por: Sarvestani, Samaneh K., et al.
Publicado: (2021)

Generation of renewable mouse intestinal epithelial cell monolayers and organoids for functional analyses
por: Moorefield, Emily C., et al.
Publicado: (2018)

Isolation of Biopsy-Derived, Human Cervical Keratinocytes Propagated as Monolayer and Organoid Cultures
por: Villa, Peter L., et al.
Publicado: (2018)

Effects of undigested protein-rich ingredients on polarised small intestinal organoid monolayers
por: Kar, Soumya K., et al.
Publicado: (2020)

Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research
por: Yamashita, Tomoki, et al.
Publicado: (2021)

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier
por: Jelinsky, Scott A, et al.
Publicado: (2022)

Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
por: Birimberg-Schwartz, Liron, et al.
Publicado: (2023)

Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn’s disease
por: Sæterstad, Siri, et al.
Publicado: (2022)

Temporal variability in quantitative human gut microbiome profiles and implications for clinical research
por: Vandeputte, Doris, et al.
Publicado: (2021)

Efficacy of JAK inhibitors in Ulcerative Colitis
por: Ferrante, Marc, et al.
Publicado: (2020)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Intestinal Organoids in Colitis Research: Focusing on Variability and Cryopreservation
por: zur Bruegge, Talke F., et al.
Publicado: (2021)

Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn’s Disease or Ulcerative Colitis
por: Vermeire, Séverine, et al.
Publicado: (2020)

Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet-like organoids
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_rh8b2j4a0tmbprse4bu0kdafpg